Cytokines as potential markers of covid-19 severity and outcomes

Y Fedorchenko, O Zimba - … Asian Journal of Medical Hypotheses and …, 2022 - cajmhe.com
The continual propagation of SARS-CoV-2 has changed health care systems globally.
Ranging degrees of clinical severity in COVID-19 patients have been noted in numerous …

[PDF][PDF] Cytokine varieties and cytokine storms in COVID-19: a review

ASM Giasuddin, KA Jhuma, RS Giasuddin… - Int. J. Clin. Exp. Med …, 2021 - academia.edu
Cytokines are heterogeneous group of protein cell regulators having many (pleotropic)
activities produced by a wide variety of cells in the body. They have made tremendous …

[PDF][PDF] Pro-and anti-inflammatory Cytokines in Coronavirus Disease 2019

BH Al-Ghurabi, LG Al-Saadi… - Medico-legal Update, 2020 - researchgate.net
It has long been believed that cytokines have an important function in immunopathology
during viral infection. Coronavirus disease 2019 (Covid-19) is a contagious viral disease …

Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity

Y Tang, J Sun, H Pan, F Yao, Y Yuan, M Zeng, G Ye… - Cytokine, 2021 - Elsevier
Cytokines play pleiotropic, antagonistic, and collaborative in viral disease. The high
morbidity and mortality of coronavirus disease 2019 (COVID-19) make it a significant threat …

Cytokine signature associated with disease severity in COVID-19

J Guo, S Wang, H Xia, D Shi, Y Chen, S Zheng… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) broke out and then became a global epidemic at the
end of 2019. With the increasing number of deaths, early identification of disease severity …

Cytokine signature and COVID-19 prediction models in the two waves of pandemics

S Cabaro, V D'Esposito, T Di Matola, S Sale… - Scientific Reports, 2021 - nature.com
In Europe, multiple waves of infections with SARS-CoV-2 (COVID-19) have been observed.
Here, we have investigated whether common patterns of cytokines could be detected in …

Cytokines from bench to bedside: A retrospective study identifies a definite panel of biomarkers to early assess the risk of negative outcome in COVID-19 patients

M Fabris, F Del Ben, E Sozio, AP Beltrami… - International Journal of …, 2022 - mdpi.com
The main aim of this study was to identify the most relevant cytokines which, when assessed
in the earliest stages from hospital admission, may help to select COVID-19 patients with …

Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19

H Fouladseresht, M Doroudchi, N Rokhtabnak… - Cytokine & growth factor …, 2021 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), appears with a wide spectrum of mild-to-critical …

The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)

M Ghofrani Nezhad, G Jami, O Kooshkaki… - Journal of Interferon & …, 2023 - liebertpub.com
Cytokine storm refers to the overproduction of immune and inflammatory cells and their
proteins (cytokines)[interleukin (IL)-1 and IL-6] causing acute respiratory distress syndrome …

COVID-19 biology: cytokine storms and their implications

N Atceken, G Kozalak - Stem Cells, 2024 - Elsevier
COVID-19 disease presents in asymptomatic and various symptomatic forms among
individuals. It is thought to be caused by the immune response of individuals. In severe and …